Sort
21,281 grants matching “influenza”
Targeting SARS-CoV-2 induced lung immunopathology using novel genetic mouse models
$190,161Alexei V Tumanov · University Of Texas Hlth Science Center · R21 · FY2023 · AI
IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND GENITAL MOCOSAL IMMUNITY
$190,131Michael K Axthelm · Oregon Health & Science University · P51 · FY2010 · RR
What Precursors Become Lung-Resident CD4 Memory that Protect Against Respiratory Infections or Cause Lung Pathology?
$190,131Priyadharshini Devarajan · State University New York Stony Brook · R21 · FY2025 · AI
Dissecting 3 processing pathways that generate class II-restricted flu epitopes
$190,069Laurence Crane Eisenlohr · Thomas Jefferson University · R21 · FY2008 · AI
RSV-induced M2 macrophage differentiation: role of TLR4/PPARg/RXR signaling axis (80)
$190,063Stefanie N. Vogel · University Of Maryland Baltimore · R21 · FY2022 · AI
ISG15 REGULATION OF ANTIVIRAL IMMUNE RESPONSES
$190,000Deborah J Lenschow · Washington University · R21 · FY2007 · AI
Drop-of-blood technology for diagnosis and therapeutic drug monitoring in patients with infectious disease
$190,000Damir B Khismatullin · Tulane University Of Louisiana · R21 · FY2023 · EB
Receptor tyrosine kinase signaling and influenza viral RNA synthesis
$190,000Yuying Liang · University Of Minnesota · R21 · FY2012 · AI
Integrin regulation of memory CD8 T cells
$190,000Yoji Shimizu · University Of Minnesota · R21 · FY2016 · AI
Drop-of-blood technology for diagnosis and therapeutic drug monitoring in patients with infectious disease
$190,000Damir B Khismatullin · Tulane University Of Louisiana · R21 · FY2024 · EB
Role of OCIAD1 in RIG-I-mediated STAT1 signaling pathway
$190,000Shitao Li · Tulane University Of Louisiana · R21 · FY2023 · AI
Effectiveness and Safety of Tdap Immunization in Pregnancy
$190,000Sylvia Irene Becker-Dreps · Univ Of North Carolina Chapel Hill · R21 · FY2016 · AI
Role of interferon lambda in host protection during aging
$190,000Rudragouda Channappanavar · University Of Tennessee Health Sci Ctr · R21 · FY2019 · AG
Novel inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR)
$189,956Yongcheng Song · Baylor College Of Medicine · R21 · FY2011 · AI
Structure and function of influenza A virus PDZ-binding motif
$189,956Andrew P Rice · Baylor College Of Medicine · R21 · FY2011 · AI
Development of therapeutic fusion inhibitor peptides for Measles encephalitis
$189,861Matteo Porotto · Weill Medical Coll Of Cornell Univ · R21 · FY2012 · NS
Mathematical Modeling of Influenza Severity in Outbred Mice
$189,830John F Alcorn · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · AI
The role of PMNs and CD73 in host-resistance against S. pneumoniae / influenza A virus co-infection
$189,818Elsa Bou Ghanem · State University Of New York At Buffalo · R21 · FY2024 · AI
Stenotrophomonas maltophilia TfcA and TfcB: Antibacterial T4SS effectors from an emerging human pathogen
$189,810Nicholas Philip Cianciotto · Northwestern University At Chicago · R21 · FY2024 · AI
Administrative Core
$189,630Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2021 · AI
Core D: Clinical Recruitment
$189,629Albert C Shaw · Yale University · U19 · FY2020 · AI
Improving mRNA vaccines with extracellular vesicle-associated immunogens
$189,627Michael R. Farzan · Boston Children'S Hospital · R21 · FY2023 · AI
RNA virus capture of host chemokines: Understanding novel viral mechanisms of immune manipulation
$189,599Andrew Brownell Allison · University Of Florida · R21 · FY2023 · AI
RELM Peptides Alter Lung Defense
$189,583Thomas R Korfhagen · Cincinnati Childrens Hosp Med Ctr · R21 · FY2009 · AI
Emerging Trends in Antibiotic Use and Their Impact on Primary Care for Children
$189,582Jonathan A Finkelstein · Boston Children'S Hospital · K24 · FY2012 · HD